Lygos closes venture financing
Synthetic biology startup, Lygos, has announced the closure of its US$13 million venture financing to target the oil-based specialty chemical industry.
Synthetic biology startup, Lygos, has announced the closure of its US$13 million venture financing to target the oil-based specialty chemical industry.